Columbus, OH
Joined August 2022
Excited to share our upcoming presentations at #ASCO2026 from the @HasanovLab @OhioStatePIIO and collaborators. This year, our team will present 12 studies spanning: hasanov-lab.github.io/public… 🤖 AI/ML precision oncology 🧠 RCC brain metastasis biology 🧫 Spatial & single-cell transcriptomics 🌎 Real-world outcomes research with ML models 💻 In silico clinical trial modeling These projects reflect our 💻 #CodetoClinic 👩‍⚕️👨‍⚕️translational framework, integrating computational oncology, multi-omics, and clinical research to advance precision cancer care. Grateful to our incredible trainees, collaborators, patients, and mentors who made this work possible. hasanov-lab.github.io/team/ @OSUCCC_James @ASCOPost @ASCO @KidneyCancer @kidneycan @urotoday @OncoAlert @oncodaily @OncLive #KidneyCancer #BrainMetastases #PrecisionOncology #AIinOncology #SpatialBiology #SingleCell #TranslationalResearch
2
7
3
26
3,573
Elshad Hasanov, MD, PhD retweeted
🌍 Two days of connection, learning and collaboration! The 2026 IKCC Global Kidney Cancer Summit brought together more than 50 patient advocates, healthcare professionals and kidney cancer experts from around the world in Prague, Czech Republic, on 10–11 October.
1
1
2
184
Congratulations to @OSUCCC_James, @OhioStateMedOnc, #PIIO physician-scientist, Dr. Elshad Hasanov (@HasanovLab) on receiving a @GatewayforCR award to fund ZUMRA study, a multicenter phase II clinical trial for patients with #KidneyCancer and #BrainMetastasis! ZUMRA study will test zanzalintinib alone or in combination with belzutifan in patients with untreated or progressive #BrainMetastases, a population often excluded from major clinical trials. The study will evaluate whether these treatments shrink brain metastases, while also assessing safety, duration of cancer control, and survival. An important step toward expanding treatment options and bringing hope to patients with challenging-to-treat kidney cancer. #KidneyCancer #ClinicalTrials #CancerResearch
7
21
717
Elshad Hasanov, MD, PhD retweeted
👏Congrats to @HasanovLab on receiving a @GatewayforCR award for a multicenter phase 2 study of zanzalintinib & combination therapies in untreated or progressive brain metastases in renal cell carcinoma
1
5
12
515
🎊Congratulations🎊 to our own @eric_facs who was recognized as an @OSUCCC_James 2026 Service Line Physician Champion at the recent Annual James Physician Recognition Celebration! We’re proud to celebrate this well-deserved award and Dr. Singer’s dedication to our patients 👏
4
1
32
1,412
Elshad Hasanov, MD, PhD retweeted
📢 Today, on World Cancer Research Day, the 5th IKCC Global Patient Survey on Kidney Cancer is now open! People who have been diagnosed with kidney cancer and carers are invited to share patient experiences and insights in the online survey: bit.ly/IKCC_Kidney_Cancer_Gl…
1
1
2
4
1,817
🧬 Join #PIIO for a Special Research Seminar featuring Dr. @HindRafei, Assistant Professor and Physician-Scientist at UT MD Anderson Cancer Center. 🔬 “Targeting cAMP signaling and metabolism to improve cellular immunotherapy in the tumor microenvironment” 📅 Sept. 16 | 12–1 PM 📍 BRT 115 🍕 Pizza will be provided #CancerResearch #Immunotherapy #CellTherapy
4
1
8
2,666
Elshad Hasanov, MD, PhD retweeted
📝New publication from @HasanovLab & colleagues in @ESMO_Open: Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases doi.org/10.1016/j.esmoop.202…
2
9
566
Elshad Hasanov, MD, PhD retweeted
Profoundly grateful for the continuous guidance of Dr. Elshad & Dr. Merve Hasanov, and the support of entire @HasanovLab @OSUCCC_James @OhioStatePIIO for making this possible. @ASCO / @NeuroOnc #CNSMetastasesConference
Our trailblazer @ZuhairMajeed presented #BrainMetCompass at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference! 🧠🧭 💻 Try BrainMetCompass: hasanovlab-brainmetcompass.s… 🎯 PREDICT → PERSONALIZE → PREVENT #BrainMetCompass is our #CodetoClinic ML model designed to predict an individual patient’s risk of developing brain metastases using clinical and tumor genomic data. Opening the door to personalized CNS surveillance, diagnosis at asymptomatic stage and ultimately prevention. The model is patented by @OhioState and is available for licensing by interested sequencing companies. Proud of Zuhair and our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team for taking another step from #CodetoClinic.
3
1
12
1,512
Excited to share our new #insilicoMetMap model, developed by our 🌟💫🌟 PhD student @PengLi_AI 🧠💻 We asked a different question: Can we learn from METMAP experiments and predict brain-metastatic potential for cell lines that have never been tested? Creating #insilicoMetMap and identifying penetrant-like states and candidate biological targets for further experimental testing. This is exactly how we envision #CodeToClinic: using existing experimental and multi-omics data to build computational models that can prioritize bench experiments, generate biological hypotheses, and potentially reduce the time and resources required for discovery. Congratulations, Peng, and the entire @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team! @NeuroOnc @ASCO
5
1
21
1,397
Our trailblazer @ZuhairMajeed presented #BrainMetCompass at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference! 🧠🧭 💻 Try BrainMetCompass: hasanovlab-brainmetcompass.s… 🎯 PREDICT → PERSONALIZE → PREVENT #BrainMetCompass is our #CodetoClinic ML model designed to predict an individual patient’s risk of developing brain metastases using clinical and tumor genomic data. Opening the door to personalized CNS surveillance, diagnosis at asymptomatic stage and ultimately prevention. The model is patented by @OhioState and is available for licensing by interested sequencing companies. Proud of Zuhair and our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team for taking another step from #CodetoClinic.
4
1
13
2,030
Our 🌟 PhD student @MostafaIHA is presenting two posters at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference. One highlights our single-cell and spatial characterization of renal cell carcinoma brain metastases, uncovering how tumor cells adapt to the brain microenvironment and interact with its immune and stromal landscape. bioRxiv preprint: pubmed.ncbi.nlm.nih.gov/4214… The second explores an interpretable machine-learning model integrating genomic mutations and copy-number alterations to predict survival across patients with brain metastases. academic.oup.com/noa/article… Proud to see Mostafa bringing together multi-omics, tumor biology, and AI #CodetoClinic as we work toward better understanding and treating brain metastasis. Great work, Mostafa, and congratulations to the entire team @OSUCCC_James @OhioStatePIIO @OSUWexMed and our collaborators @UTMDAnderson @EmoryUniversity @Hacettepe1967 @EJonasch @bilenma @hanalioglu @ACasasent @nicholas_navin #BrainMetastases #KidneyCancer #SingleCell #SpatialBiology #MachineLearning #PrecisionOncology
5
1
23
2,035
Congratulations to 💫 biostatistician @Tubitak scholar @semihaxozgul on a special milestone: concurrent publications in @myESMO @ESMO_Open and @NeuroOnc #NeuroOncAdvances, alongside her poster presentation at the 2026 SNO/@ASCO #CNSMetastasesConference! 🎉 Her work, “Era-Specific Prognostic Factors and an Interpretable Machine-Learning Survival Model for Renal Cell Carcinoma Brain Metastases,” brings together clinical oncology and interpretable AI to better understand outcomes and personalize prognostication for patients with RCC brain metastases. Proud to see this work from our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team, in collaboration with @UTMDAnderson, move from data → #CodetoClinic. 📄 ESMO Open: sciencedirect.com/science/ar… 📄 Neuro-Oncology Advances #cofirst @ZuhairMajeed : academic.oup.com/noa/article… 💻 Interactive models: hasanov-lab.github.io/tools/… Congratulations, Semiha, and the entire team! 👏 #BrainMetastases #KidneyCancer #MachineLearning #PrecisionOncology #SNO2026 #ASCO
5
8
24
1,611
Proud of our team at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference in Boston, presenting 5 studies: 2 oral presentations and 3 posters, spanning AI/ML prediction of brain metastasis, multi-omics neural networks, genomic survival modeling, and single-cell characterization of RCC brain metastases. Exciting to see our trainees leading these efforts and advancing our mission to better predict, understand, and ultimately prevent brain metastasis. #CodetoClinic #BrainMetastases #CNSMetastases #SNO2026 #ASCO #AI #PrecisionOncology @OhioState @OSUCCC_James @OhioStateMedOnc @OhioStatePIIO
3
10
29
2,034
No limits @Pelotonia Weekend On every front in the fight against cancer. 💚 💚 💚 This weekend was a reminder that there are many ways to change the future of cancer care: caring for patients, advancing research, sharing science, educating colleagues, volunteering, fundraising, riding, and even building new collaborations on the bike. 🚴🏻🚴‍♀️🚴‍♂️ That’s what makes @Pelotonia so special. Every mile, every conversation, and every act of generosity brings us one step closer to a #CancerFreeWorld. @HasanovLab proud to be part of this incredible community @Pelotonia @OhioStatePIIO @OhioStateMedOnc @OSUCCC_James @OSUWexMed @OhioState
7
2
31
3,049
🤖 #ArtificialIntelligence is helping unlock the future of #KidneyCancer care. At @OSUCCC_James, @Pelotonia-funded researcher Dr. Elshad Hasanov (@HasanovLab) is using #AI to identify which treatments may work best for each patient.
3
2
10
1,423
Excited to share that our team has received @Pelotonia Idea Award to develop AI-powered tools that help personalize treatment for kidney cancer. By combining spatial biology with artificial intelligence, we aim to predict which treatment are most likely to benefit each patient and bring more precision to cancer care. As I prepare for my next Pelotonia ride, I’d be grateful for your support. 100% of every dollar raised through Pelotonia goes directly to cancer research. my.pelotonia.org/donate?reci… Together, we can help turn ideas into better treatments for patients. @eric_facs @EJonasch @UTMDAnderson @bilenma @EmoryUniversity Dr.Shakya Dr.Niazi @OSUCCC_James @OhioStatePIIO #Pelotonia #CancerResearch #KidneyCancer #AI #PrecisionOncology #CodetoClinic #BikeforBrainMetastasis
1
5
1
27
3,041
Elshad Hasanov, MD, PhD retweeted
When should someone with #KidneyCancer consider a clinical trial? @eric_facs @OSU_Urology discusses the important role clinical trials play in advancing kidney cancer care, when patients should start talking with their care team about trial opportunities, and why meetings like KCRS are so valuable for bringing the kidney cancer community together. #KCRS26 #AcceleratingCures
8
1
12
918
Elshad Hasanov, MD, PhD retweeted
Why do some RCCs develop brain metastases? The answer may be written in the genome. Excellent presentation by @HasanovLab highlighting recurrent genomic alterations associated with RCC brain metastases. #AcceleratingCures #KCRS26 @kidneycan @DrChoueiri @HHammersMD @IKCCorg @advocatekidneys @DrRanaMcKay @NazliDizman @MikeSerzanMD @crisbergerot @Uromigos @OncoAlert @OpenMedicineHQ @montypal @arihakimi @TiansterZhang @AlbigesL @ReneeSaliby @VincentWenxinXu @ChristianRolfo @KimrynRathmell @OSUCCC_James
16
32
1,570